SCHEMBL17694329

SCHEMBL17694329

CC#CCOc1ccc2cc(-c3ccc(-c4ccc(-c5ccc(-c6ccc7cc(OCCCC)ccc7c6)cc5F)c5nsnc45)c(F)c3)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARA P10276 1/20 0.35
▸ RARB P10826 1/20 0.35
▸ RAB9A P51151 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ S1PR1 P21453 2/20 0.34
▸ S1PR3 Q99500 2/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ CASR P41180 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17694360 0.93 RARB (0.41) RARARARBRAB9ALMNAPOLB
SCHEMBL17696654 0.91 RARA (0.40) RARARARBRAB9ALMNAPOLB
SCHEMBL16265191 0.83 RARB (0.48) RARARARBRAB9ALMNAPOLB
SCHEMBL19636766 0.79 RARA (0.45) RARARARBRAB9ALMNAPOLB
SCHEMBL16265268 0.77 RARB (0.43) RARARARBRAB9ALMNAPOLB
SCHEMBL19456752 0.77 RARB (0.43) RARARARBRAB9ALMNAPOLB
SCHEMBL17694332 0.76 RARB (0.43) RARARARBRAB9AKDM4E
SCHEMBL16265325 0.76 RARB (0.41) RARARARBRAB9ALMNAPOLB
SCHEMBL17694325 0.76 PTPN11 (0.45) RARBCA12CA1CA2CA3
SCHEMBL25070289 0.75 HSD17B1 (0.47) RAB9ACYP19A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 — — US disclosed
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2016-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND CRY1, SLC25A1, CRY2 RARA 175/4885RARB 172/4885RAB9A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback